Compare BCRX & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | LASR |
|---|---|---|
| Founded | 1986 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 1995 | 2018 |
| Metric | BCRX | LASR |
|---|---|---|
| Price | $8.51 | $66.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | $20.82 | ★ $50.56 |
| AVG Volume (30 Days) | ★ 4.2M | 1.8M |
| Earning Date | 05-15-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 62.99 |
| EPS | ★ 1.21 | N/A |
| Revenue | $25,186,000.00 | ★ $191,359,000.00 |
| Revenue This Year | N/A | $9.24 |
| Revenue Next Year | $12.55 | $13.99 |
| P/E Ratio | $7.23 | ★ N/A |
| Revenue Growth | N/A | ★ 38.09 |
| 52 Week Low | $6.00 | $6.20 |
| 52 Week High | $11.31 | $69.52 |
| Indicator | BCRX | LASR |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 61.22 |
| Support Level | $7.95 | $27.61 |
| Resistance Level | $8.68 | $69.52 |
| Average True Range (ATR) | 0.31 | 5.03 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 70.43 | 75.05 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.